A different perspective into clinical symptoms in CPT I deficiency
Carnitine palmitoyltransferase I (CPT I) deficiency is an autosomal recessive disorder causing long-chain fatty acid oxidation defect, characterized by metabolic decompensation episodes accompanied by hypoketotic hypoglycemia, hepatomegaly, seizures, renal tubular acidosis, and hyperammonemia. The a...
Main Authors: | Mehmet Cihan Balci, Meryem Karaca, Arzu Selamioglu, Huseyin Kutay Korbeyli, Asli Durmus, Belkis Ak, Tugba Kozanoglu, Gulden Fatma Gokcay |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Molecular Genetics and Metabolism Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426923000782 |
Similar Items
-
Increasing maternal age associates with lower placental CPT1B mRNA expression and acylcarnitines, particularly in overweight women
by: Hannah E. J. Yong, et al.
Published: (2023-05-01) -
Recurrent rhabdomyolysis caused by palmitoyltransferase II (CPT-2) deficiency but complete normal acylcarnitine profile: A patient presentation and review of the literature
by: Chih-Hsuan Lu, et al.
Published: (2024-12-01) -
Carnitine PT II Deficiency and Cerebral Dysgenesis
by: J Gordon Millichap
Published: (1995-10-01) -
Carnitine O-Acetyltransferase as a Central Player in Lipid and Branched-Chain Amino Acid Metabolism, Epigenetics, Cell Plasticity, and Organelle Function
by: Mariateresa Volpicella, et al.
Published: (2025-02-01) -
Characterization of Mitochondrial Content and Respiratory Capacities of Broiler Chicken Skeletal Muscles with Different Muscle Fiber Compositions
by: Yuki Hakamata, et al.
Published: (2018-07-01)